Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSmith & Nephew Regulatory News (SN.)

Share Price Information for Smith & Nephew (SN.)

Share Price is delayed by 15 minutes
Get Live Data
1,147.00    8.00 (0.70%)
Bid:
1,147.00
Ask:
1,147.50
Spread: 0.50 (0.044%)
Market Cap: £9.74b
SN. Live PriceLast checked at - London Stock Exchange

Intraday Smith & Nephew Share Chart

Director/PDMR Shareholding

23 Aug 2022 16:25

RNS Number : 9708W
Smith & Nephew Plc
23 August 2022
 

 

SMITH & NEPHEW PLC

 

23 August 2022

 

NOTIFICATION AND PUBLIC DISCLOSURE IN ACCORDANCE WITH THE REQUIREMENTS OF THE EU MARKET ABUSE REGULATION OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM.

 

On 23 August 2022 the following ordinary shares of US$0.20 and American Depository Receipts (ADR) (the "Shares") in Smith & Nephew plc (the "Company") were purchased in line with Smith & Nephew plc's Remuneration Policy to pay part of its Non-Executive Directors' fees in Shares. These Shares were purchased net of tax and expenses. One ADR represents two ordinary shares.

 

The following relates to Erik Engstrom, Robin Freestone, Jo Hallas, Katarzyna Mazur-Hofsaess, Rick Medlock, Roberto Quarta and Angie Risley, included in this notification:

 

Reason for the notification

Initial notification /Amendment

Initial notification

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

Name

Smith & Nephew plc

LEI

213800ZTMDN8S67S1H61

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

Description of the financial instrument, type of instrument

Smith & Nephew plc ordinary shares of USD 0.20 each

Identification code

ISIN: GB0009223206

Nature of the transaction

Share purchase in lieu of part of annual fees.

Date of Transaction

2022 - 08 - 23

Place of Transaction

London Stock Exchange (XLON)

 

The following relates to John Ma, Marc Owen and Bob White, included in this notification:

 

Reason for the notification

Initial notification /Amendment

Initial notification

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

Name

Smith & Nephew plc

LEI

213800ZTMDN8S67S1H61

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

Description of the financial instrument, type of instrument

Smith & Nephew plc SPON ADR American Depositary Shares

Identification code

ISIN: US83175M2052

Nature of the transaction

Share purchase in lieu of part of annual fees.

Date of Transaction

2022 - 08 - 23

Place of Transaction

New York Stock Exchange (XNYS)

 

Name

Director / PDMR

Price

Volume

Aggregated information

Total Share Holding following the transaction *

Total Share Holding as a % of the Company's ISC following the transaction *

Roberto Quarta

Chair

£10.105

5,832

ordinary shares

N/A Single Transaction

73,300

ordinary shares (including 12,000 ADRs)

0.00835%

Erik Engstrom

Non-Executive Director

£10.105

332

ordinary shares

N/A Single Transaction

16,774

ordinary shares

0.00191%

Robin Freestone

Non-Executive

Director

£10.105

332

ordinary shares

N/A Single Transaction

16,752

ordinary shares

0.00191%

Jo Hallas

Non-Executive Director

£10.105

332 ordinary shares

N/A Single Transaction

5,332 ordinary shares

0.00061%

Katarzyna Mazur-Hofsaess

Non-Executive Director

£10.105

514

ordinary

shares

N/A Single Transaction

880

ordinary shares

0.00010%

Rick Medlock

Non-Executive Director

£10.105

300

ordinary shares

N/A Single Transaction

3,564

ordinary shares

0.00041%

Angie Risley

Non-Executive Director

£10.105

332

ordinary shares

N/A Single Transaction

5,343

ordinary shares

0.00061%

John Ma

Non-Executive Director

$24.51

314

ADRs

N/A Single Transaction

924

ordinary shares (held via 462 ADRs)

0.00011%

Marc Owen

Non-Executive Director

$24.51

203

ADRs

N/A Single Transaction

8,478

ordinary shares (held via 4,239 ADRs)

0.00097%

Bob White

Non-Executive Director

$24.51

314

ADRs

N/A Single Transaction

7,284

ordinary shares (held via 3,642 ADRs)

0.00083%

 

* including those held by Persons Closely Associated with the Director/PDMR.

 

Sarah Carne

Deputy Company Secretary

Smith & Nephew plc

Tel: +44 (0)1923 477410

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHFLFFETSIVFIF
Date   Source Headline
5th Jun 202612:12 pmRNSTransaction in Own Shares
4th Jun 20264:05 pmRNSDirector/PDMR Shareholding
3rd Jun 202611:21 amRNSDirector/PDMR Shareholding
3rd Jun 202610:35 amRNSAdmission to Trading
1st Jun 20263:10 pmRNSTotal Voting Rights
29th May 202610:37 amRNSTransaction in Own Shares
27th May 20269:31 amRNSPre Stabilisation Notice
22nd May 20261:32 pmRNSAdmission to Trading
22nd May 20269:58 amRNSTransaction in Own Shares
20th May 202611:25 amRNSDirector/PDMR Shareholding
19th May 20268:53 amRNSHolding(s) in Company
15th May 202612:28 pmRNSTransaction in Own Shares Replacement
15th May 202611:41 amRNSTransaction in Own Shares
14th May 20269:25 amRNSHolding(s) in Company
12th May 20264:03 pmRNSSterling Amount of Dividend
8th May 20267:00 amRNSShare Buyback Programme
6th May 20262:25 pmRNSResult of AGM
6th May 20267:00 amRNSSmith+Nephew First Quarter 2026 Trading Update
1st May 20261:10 pmRNSTotal Voting Rights
27th Apr 20267:00 amRNSExpert surgeons insights event for investors
22nd Apr 20268:46 amRNSNotice of Results
16th Apr 202611:12 amRNSDirector/PDMR Shareholding
15th Apr 20263:46 pmRNSDirector Declaration
14th Apr 20262:59 pmRNSReplacement: Annual Financial Report & AGM Notice
1st Apr 202612:23 pmRNSTotal Voting Rights
24th Mar 20264:16 pmRNSDirector/PDMR Shareholding
24th Mar 20268:45 amRNSHolding(s) in Company
16th Mar 20263:08 pmRNSAnnual Financial Report & Notice of AGM
16th Mar 20263:08 pmRNSAnnual Financial Report & Notice of AGM
10th Mar 20262:30 pmRNS-RSmith+Nephew launches next-generation ALLEVYN™ COMPLETE CARE Foam Dressing - designed for high performance in wound management and pressure injury prevention
5th Mar 20267:30 amRNSDirector Declaration
2nd Mar 20261:36 pmRNSTotal Voting Rights
2nd Mar 20267:00 amRNSFinal Results
5th Feb 202611:56 amRNSNotice of Results
2nd Feb 20264:00 pmRNSBLOCK LISTING SIX MONTHLY RETURN
2nd Feb 20263:05 pmRNSTotal Voting Rights
23rd Jan 20262:00 pmRNSDirector/PDMR Shareholding
21st Jan 20264:11 pmRNSCompletion of Acquisition
12th Jan 20264:30 pmRNSAcquisition of Integrity Orthopaedics
2nd Jan 202610:07 amRNSTotal Voting Rights
8th Dec 20257:00 amRNSNew Strategy and 2028 Financial Targets
1st Dec 20254:10 pmRNSTotal Voting Rights
19th Nov 202510:00 amRNSDirector/PDMR Shareholding
18th Nov 202510:18 amRNSHolding(s) in Company
12th Nov 20259:24 amRNSDirector/PDMR Shareholding
11th Nov 20254:40 pmRNSHolding(s) in Company
10th Nov 20251:46 pmRNSDirector/PDMR Shareholding
7th Nov 20259:38 amRNSDirector/PDMR Shareholding
7th Nov 20259:35 amRNSDirector/PDMR Shareholding
6th Nov 20257:01 amRNSDirectorate change

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.